Brighthouse Financial, Inc.
BHFNasdaqFinancials · Life Insurance · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.77B | $4.72B | $4.12B | $6.87B | $4.98B | $8.50B |
| Operating income | — | — | — | — | — | — |
| Net income | $433.0M | $388.0M | −$1.11B | $3.88B | $1.64B | −$1.06B |
| Total assets | $241.80B | $238.54B | $236.34B | $224.85B | $262.26B | $247.87B |
| Total liabilities | $234.97B | $233.51B | $231.33B | $219.25B | $253.81B | $229.78B |
| Equity | $6.77B | $4.96B | $4.94B | $5.53B | $16.14B | $18.02B |
| EPS (diluted) | $5.71 | $4.64 | $-18.39 | $51.30 | $18.39 | $-11.58 |
| Shares out. | 58.1M | 62.9M | 67.7M | 76.6M | 87.4M | 105.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 6.4%
- Return on equity
- 6.4%
- Return on assets
- 0.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 97.2%
- Debt / equity
- 34.72×
- Book value / share
- $116.57
- Revenue growth (YoY)
- 43.2%
- Net income growth (YoY)
- 11.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 0.1%clean
- Piotroski F-Score
- 6/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 3 good- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Dodge & CoxPassive (13G)Mar 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Wetzel Paul M.Director | May 1, 2026 | Option exercise | 1,120 | $0.00 |
| Juel CarolDirector | May 1, 2026 | Option exercise | 3,361 | $0.00 |
| Pavlovich Melissa B.Officer — Chief Accounting Officer | Apr 8, 2026 | Option exercise | 5,581 | — |
| Pavlovich Melissa B.Officer — Chief Accounting Officer | Feb 27, 2026 | Grant | 1,302 | $0.00 |
| Steigerwalt Eric TOfficer — President and CEO | Feb 27, 2026 | Grant | 75,577 | $0.00 |
| Spehar Edward A.Officer — EVP & Chief Financial Officer | Feb 27, 2026 | Grant | 18,786 | $0.00 |
| Lin AllieOfficer — EVP & General Counsel | Feb 27, 2026 | Grant | 8,974 | $0.00 |
| Lambert MylesOfficer — EVP, Chief Operating Officer | Feb 27, 2026 | Grant | 12,955 | $0.00 |
| Huss VondaOfficer — EVP & Chief HR Officer | Feb 27, 2026 | Grant | 8,879 | $0.00 |
| Rosenthal JohnOfficer — EVP & Chief Investment Officer | Feb 27, 2026 | Grant | 15,520 | $0.00 |
| Lambert MylesOfficer — EVP,Chief Mktg.& Dist. Officer | Jul 1, 2025 | Option exercise | 23,468 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.7M | 11.7 | -0.8% |
| Apr 30, 2026 | 6.7M | 18.8 | +1.4% |
| Apr 15, 2026 | 6.6M | 10.0 | +1.1% |
| Mar 31, 2026 | 6.5M | 11.0 | +0.1% |
| Mar 13, 2026 | 6.5M | 7.7 | +0.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Results of operationsFeb 23, 2026
- Shareholder vote · Regulation FD disclosureFeb 12, 2026
- Results of operationsNov 7, 2025
- Other material eventNov 6, 2025
- Entered a material agreement · Results of operations · Regulation FD disclosureNov 6, 2025
- Director / officer changeSep 2, 2025
- Results of operations · Regulation FD disclosureAug 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spun off from MetLifeMET · Aug 4, 2017
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.